Go Pro

Zentek (ZTEK) Competitors

Zentek logo
$0.48 +0.00 (+0.69%)
Closing price 04:00 PM Eastern
Extended Trading
$0.47 -0.01 (-2.04%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ZTEK vs. SAFX, CBUS, AMTX, ARQ, and FSI

Should you buy Zentek stock or one of its competitors? MarketBeat compares Zentek with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Zentek include XCF Global Capital (SAFX), Cibus (CBUS), Aemetis (AMTX), ARQ (ARQ), and Flexible Solutions International (FSI). These companies are all part of the "chemicals" industry.

How does Zentek compare to XCF Global Capital?

XCF Global Capital (NASDAQ:SAFX) and Zentek (NASDAQ:ZTEK) are both small-cap chemicals companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

XCF Global Capital has a net margin of 300.85% compared to Zentek's net margin of -5,848.76%. Zentek's return on equity of -81.95% beat XCF Global Capital's return on equity.

Company Net Margins Return on Equity Return on Assets
XCF Global Capital300.85% -588.22% -29.08%
Zentek -5,848.76%-81.95%-57.78%

52.3% of XCF Global Capital shares are owned by institutional investors. Comparatively, 0.8% of Zentek shares are owned by institutional investors. 0.1% of XCF Global Capital shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

XCF Global Capital has a beta of -0.32, suggesting that its stock price is 132% less volatile than the broader market. Comparatively, Zentek has a beta of 0.47, suggesting that its stock price is 53% less volatile than the broader market.

XCF Global Capital currently has a consensus price target of $0.70, suggesting a potential upside of 41.82%. Given XCF Global Capital's stronger consensus rating and higher possible upside, equities research analysts plainly believe XCF Global Capital is more favorable than Zentek.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
XCF Global Capital
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Zentek
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

XCF Global Capital has higher revenue and earnings than Zentek. Zentek is trading at a lower price-to-earnings ratio than XCF Global Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
XCF Global Capital$21.16M7.76$74.02M-$0.68N/A
Zentek$166.05K365.87-$7.07M-$0.07N/A

In the previous week, XCF Global Capital had 2 more articles in the media than Zentek. MarketBeat recorded 4 mentions for XCF Global Capital and 2 mentions for Zentek. XCF Global Capital's average media sentiment score of 0.40 beat Zentek's score of 0.29 indicating that XCF Global Capital is being referred to more favorably in the media.

Company Overall Sentiment
XCF Global Capital Neutral
Zentek Neutral

Summary

XCF Global Capital beats Zentek on 12 of the 16 factors compared between the two stocks.

How does Zentek compare to Cibus?

Zentek (NASDAQ:ZTEK) and Cibus (NASDAQ:CBUS) are both small-cap chemicals companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

0.8% of Zentek shares are owned by institutional investors. Comparatively, 33.8% of Cibus shares are owned by institutional investors. 49.4% of Cibus shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Zentek has higher earnings, but lower revenue than Cibus. Zentek is trading at a lower price-to-earnings ratio than Cibus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zentek$166.05K365.87-$7.07M-$0.07N/A
Cibus$3.64M44.67-$127.08M-$1.97N/A

In the previous week, Zentek had 1 more articles in the media than Cibus. MarketBeat recorded 2 mentions for Zentek and 1 mentions for Cibus. Cibus' average media sentiment score of 1.87 beat Zentek's score of 0.29 indicating that Cibus is being referred to more favorably in the news media.

Company Overall Sentiment
Zentek Neutral
Cibus Very Positive

Zentek has a beta of 0.47, indicating that its share price is 53% less volatile than the broader market. Comparatively, Cibus has a beta of 1.65, indicating that its share price is 65% more volatile than the broader market.

Cibus has a net margin of -2,366.33% compared to Zentek's net margin of -5,848.76%. Zentek's return on equity of -81.95% beat Cibus' return on equity.

Company Net Margins Return on Equity Return on Assets
Zentek-5,848.76% -81.95% -57.78%
Cibus -2,366.33%-200.87%-28.28%

Cibus has a consensus price target of $9.00, suggesting a potential upside of 322.54%. Given Cibus' stronger consensus rating and higher possible upside, analysts clearly believe Cibus is more favorable than Zentek.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zentek
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Cibus
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Cibus beats Zentek on 11 of the 16 factors compared between the two stocks.

How does Zentek compare to Aemetis?

Zentek (NASDAQ:ZTEK) and Aemetis (NASDAQ:AMTX) are both small-cap chemicals companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

0.8% of Zentek shares are owned by institutional investors. Comparatively, 27.0% of Aemetis shares are owned by institutional investors. 13.0% of Aemetis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Aemetis had 3 more articles in the media than Zentek. MarketBeat recorded 5 mentions for Aemetis and 2 mentions for Zentek. Aemetis' average media sentiment score of 0.54 beat Zentek's score of 0.29 indicating that Aemetis is being referred to more favorably in the news media.

Company Overall Sentiment
Zentek Neutral
Aemetis Positive

Zentek has higher earnings, but lower revenue than Aemetis. Zentek is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zentek$166.05K365.87-$7.07M-$0.07N/A
Aemetis$197.63M0.57-$77M-$1.19N/A

Aemetis has a net margin of -35.43% compared to Zentek's net margin of -5,848.76%. Aemetis' return on equity of 0.00% beat Zentek's return on equity.

Company Net Margins Return on Equity Return on Assets
Zentek-5,848.76% -81.95% -57.78%
Aemetis -35.43%N/A -33.44%

Aemetis has a consensus price target of $11.88, suggesting a potential upside of 646.86%. Given Aemetis' stronger consensus rating and higher probable upside, analysts plainly believe Aemetis is more favorable than Zentek.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zentek
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Aemetis
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Zentek has a beta of 0.47, suggesting that its stock price is 53% less volatile than the broader market. Comparatively, Aemetis has a beta of 1.44, suggesting that its stock price is 44% more volatile than the broader market.

Summary

Aemetis beats Zentek on 13 of the 16 factors compared between the two stocks.

How does Zentek compare to ARQ?

ARQ (NASDAQ:ARQ) and Zentek (NASDAQ:ZTEK) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation.

In the previous week, ARQ had 3 more articles in the media than Zentek. MarketBeat recorded 5 mentions for ARQ and 2 mentions for Zentek. ARQ's average media sentiment score of 1.23 beat Zentek's score of 0.29 indicating that ARQ is being referred to more favorably in the media.

Company Overall Sentiment
ARQ Positive
Zentek Neutral

ARQ has a beta of 2, indicating that its stock price is 100% more volatile than the broader market. Comparatively, Zentek has a beta of 0.47, indicating that its stock price is 53% less volatile than the broader market.

ARQ currently has a consensus target price of $7.50, indicating a potential upside of 237.84%. Given ARQ's stronger consensus rating and higher probable upside, equities research analysts clearly believe ARQ is more favorable than Zentek.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ARQ
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Zentek
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Zentek has lower revenue, but higher earnings than ARQ. Zentek is trading at a lower price-to-earnings ratio than ARQ, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ARQ$122.14M0.78-$52.61M-$1.29N/A
Zentek$166.05K365.87-$7.07M-$0.07N/A

ARQ has a net margin of -43.93% compared to Zentek's net margin of -5,848.76%. ARQ's return on equity of -2.67% beat Zentek's return on equity.

Company Net Margins Return on Equity Return on Assets
ARQ-43.93% -2.67% -2.00%
Zentek -5,848.76%-81.95%-57.78%

18.5% of ARQ shares are owned by institutional investors. Comparatively, 0.8% of Zentek shares are owned by institutional investors. 20.1% of ARQ shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

ARQ beats Zentek on 13 of the 16 factors compared between the two stocks.

How does Zentek compare to Flexible Solutions International?

Flexible Solutions International (NYSE:FSI) and Zentek (NASDAQ:ZTEK) are both small-cap chemicals companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, risk and profitability.

Flexible Solutions International has a net margin of 10.80% compared to Zentek's net margin of -5,848.76%. Flexible Solutions International's return on equity of 10.61% beat Zentek's return on equity.

Company Net Margins Return on Equity Return on Assets
Flexible Solutions International10.80% 10.61% 7.32%
Zentek -5,848.76%-81.95%-57.78%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Flexible Solutions International
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
3.00
Zentek
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

54.3% of Flexible Solutions International shares are held by institutional investors. Comparatively, 0.8% of Zentek shares are held by institutional investors. 35.8% of Flexible Solutions International shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Zentek had 2 more articles in the media than Flexible Solutions International. MarketBeat recorded 2 mentions for Zentek and 0 mentions for Flexible Solutions International. Zentek's average media sentiment score of 0.29 beat Flexible Solutions International's score of 0.00 indicating that Zentek is being referred to more favorably in the news media.

Company Overall Sentiment
Flexible Solutions International Neutral
Zentek Neutral

Flexible Solutions International has higher revenue and earnings than Zentek. Zentek is trading at a lower price-to-earnings ratio than Flexible Solutions International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Flexible Solutions International$39.34M1.88$2.78M$0.0696.67
Zentek$166.05K365.87-$7.07M-$0.07N/A

Flexible Solutions International has a beta of 1.63, meaning that its stock price is 63% more volatile than the broader market. Comparatively, Zentek has a beta of 0.47, meaning that its stock price is 53% less volatile than the broader market.

Summary

Flexible Solutions International beats Zentek on 12 of the 15 factors compared between the two stocks.

Get Zentek News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZTEK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZTEK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZTEK vs. The Competition

MetricZentekTechnology Services IndustryBusiness SectorNASDAQ Exchange
Market Cap$60.75M$3.89B$6.85B$12.42B
Dividend YieldN/A2.21%3.14%8.01%
P/E Ratio-6.8534.9728.6424.29
Price / Sales365.8744.52344.3795.58
Price / CashN/A36.8823.2149.39
Price / Book6.854.145.706.29
Net Income-$7.07M$31.58M$203.89M$330.86M
7 Day Performance3.41%-1.54%-1.48%-2.41%
1 Month Performance4.99%-6.81%-2.23%-0.64%
1 Year Performance-55.78%1.93%14.16%20.07%

Zentek Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZTEK
Zentek
0.3582 of 5 stars
$0.48
+0.7%
N/A-56.1%$60.75M$166.05KN/A24
SAFX
XCF Global Capital
3.5693 of 5 stars
$0.46
-2.7%
$0.70
+53.8%
N/A$151.65M$20.82MN/AN/A
CBUS
Cibus
2.3017 of 5 stars
$1.74
+15.7%
$9.00
+418.7%
+29.5%$134.95M$3.64MN/A48
AMTX
Aemetis
2.344 of 5 stars
$1.80
+1.4%
$11.88
+561.6%
-45.6%$125.61M$197.63MN/A160
ARQ
ARQ
4.443 of 5 stars
$2.17
-2.0%
$7.50
+246.4%
-59.5%$92.94M$120.34MN/A140

Related Companies and Tools


This page (NASDAQ:ZTEK) was last updated on 7/13/2026 by MarketBeat.com Staff.
From Our Partners